Literature DB >> 24072850

MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance.

Marzia Varettoni1, Silvia Zibellini, Luca Arcaini, Emanuela Boveri, Sara Rattotti, Cristiana Pascutto, Silvia Mangiacavalli, Manuel Gotti, Lara Pochintesta, Marco Paulli, Mario Cazzola.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24072850     DOI： 10.1182/blood-2013-07-513366

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  15 in total

1.  Genetic characterization of MYD88-mutated lymphoplasmacytic lymphoma in comparison with MYD88-mutated chronic lymphocytic leukemia.

Authors:  C Baer; F Dicker; W Kern; T Haferlach; C Haferlach
Journal:  Leukemia       Date:  2016-11-14       Impact factor: 11.528

2.  MYD88 mutated and wild-type Waldenström's Macroglobulinemia: characterization of chromosome 6q gene losses and their mutual exclusivity with mutations in CXCR4.

Authors:  Maria Luisa Guerrera; Nickolas Tsakmaklis; Lian Xu; Guang Yang; Maria Demos; Amanda Kofides; Gloria G Chan; Robert J Manning; Xia Liu; Jiaji G Chen; Manit Munshi; Christopher J Patterson; Jorge J Castillo; Toni Dubeau; Joshua Gustine; Ruben D Carrasco; Luca Arcaini; Marzia Varettoni; Mario Cazzola; Steven P Treon; Zachary R Hunter
Journal:  Haematologica       Date:  2018-03-29       Impact factor: 9.941

3.  IgM-MM is predominantly a pre-germinal center disorder and has a distinct genomic and transcriptomic signature from WM.

Authors:  Abdul Hamid Bazarbachi; Hervé Avet-Loiseau; Raphael Szalat; Anil Aktas Samur; Zachary Hunter; Masood Shammas; Jill Corre; Mariateresa Fulciniti; Kenneth C Anderson; Giovanni Parmigiani; Steven P Treon; Mohamad Mohty; Nikhil C Munshi; Mehmet Kemal Samur
Journal:  Blood       Date:  2021-11-18       Impact factor: 22.113

Review 4.  MYD88 Mutations: Transforming the Landscape of IgM Monoclonal Gammopathies.

Authors:  Miguel Alcoceba; María García-Álvarez; Alejandro Medina; Rebeca Maldonado; Verónica González-Calle; María Carmen Chillón; María Eugenia Sarasquete; Marcos González; Ramón García-Sanz; Cristina Jiménez
Journal:  Int J Mol Sci       Date:  2022-05-16       Impact factor: 6.208

Review 5.  Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies.

Authors:  Steven P Treon; Lian Xu; Maria Luisa Guerrera; Cristina Jimenez; Zachary R Hunter; Xia Liu; Maria Demos; Joshua Gustine; Gloria Chan; Manit Munshi; Nicholas Tsakmaklis; Jiaji G Chen; Amanda Kofides; Romanos Sklavenitis-Pistofidis; Mark Bustoros; Andrew Keezer; Kirsten Meid; Christopher J Patterson; Antonio Sacco; Aldo Roccaro; Andrew R Branagan; Guang Yang; Irene M Ghobrial; Jorge J Castillo
Journal:  J Clin Oncol       Date:  2020-02-21       Impact factor: 44.544

6.  Detection of MYD88 L265P in patients with lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia and other B-cell non-Hodgkin lymphomas.

Authors:  Sang-Yong Shin; Seung-Tae Lee; Hyun-Young Kim; Chang-Hun Park; Hee-Jin Kim; Jong-Won Kim; Seok Jin Kim; Won Seog Kim; Sun-Hee Kim
Journal:  Blood Res       Date:  2016-09-23

7.  Highly sensitive MYD88L265P mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia.

Authors:  Daniela Drandi; Elisa Genuardi; Irene Dogliotti; Martina Ferrante; Cristina Jiménez; Francesca Guerrini; Mariella Lo Schirico; Barbara Mantoan; Vittorio Muccio; Giuseppe Lia; Gian Maria Zaccaria; Paola Omedè; Roberto Passera; Lorella Orsucci; Giulia Benevolo; Federica Cavallo; Sara Galimberti; Ramón García Sanz; Mario Boccadoro; Marco Ladetto; Simone Ferrero
Journal:  Haematologica       Date:  2018-03-22       Impact factor: 9.941

8.  Detection of MYD88 L265P mutation by next-generation deep sequencing in peripheral blood mononuclear cells of Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.

Authors:  Ayako Nakamura; Chikako Ohwada; Masahiro Takeuchi; Yusuke Takeda; Shokichi Tsukamoto; Naoya Mimura; Oshima-Hasegawa Nagisa; Yasumasa Sugita; Hiroaki Tanaka; Hisashi Wakita; Nobuyuki Aotsuka; Kosei Matsue; Koutaro Yokote; Osamu Ohara; Chiaki Nakaseko; Emiko Sakaida
Journal:  PLoS One       Date:  2019-09-04       Impact factor: 3.240

Review 9.  Advances in the understanding of IgM monoclonal gammopathy of undetermined significance.

Authors:  Jonas Paludo; Stephen M Ansell
Journal:  F1000Res       Date:  2017-12-18

10.  Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance.

Authors:  Marzia Varettoni; Silvia Zibellini; Irene Defrancesco; Virginia Valeria Ferretti; Ettore Rizzo; Luca Malcovati; Anna Gallì; Matteo Giovanni Della Porta; Emanuela Boveri; Luca Arcaini; Chiara Candido; Marco Paulli; Mario Cazzola
Journal:  Haematologica       Date:  2017-10-05       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.